Market Closed -
Nyse
04:10:00 2024-05-10 pm EDT
|
5-day change
|
1st Jan Change
|
94.95
USD
|
-1.12%
|
|
+3.80%
|
+2.74%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,195
|
1,324
|
1,020
|
1,048
|
913
|
1,416
|
Enterprise Value (EV)
1 |
1,090
|
1,353
|
890.6
|
958.5
|
856.3
|
1,286
|
P/E ratio
|
20.3
x
|
19.5
x
|
24.4
x
|
7.56
x
|
41
x
|
21.3
x
|
Yield
|
2.52%
|
2.38%
|
3.13%
|
3.11%
|
3.8%
|
2.53%
|
Capitalization / Revenue
|
1.22
x
|
1.33
x
|
1.04
x
|
1.04
x
|
0.85
x
|
1.25
x
|
EV / Revenue
|
1.11
x
|
1.36
x
|
0.91
x
|
0.95
x
|
0.8
x
|
1.13
x
|
EV / EBITDA
|
10.8
x
|
14.3
x
|
10
x
|
16.3
x
|
14.8
x
|
13.8
x
|
EV / FCF
|
25.3
x
|
26.4
x
|
5.9
x
|
-22.3
x
|
-19.2
x
|
22.2
x
|
FCF Yield
|
3.96%
|
3.78%
|
17%
|
-4.49%
|
-5.2%
|
4.5%
|
Price to Book
|
1.63
x
|
1.7
x
|
1.28
x
|
1.16
x
|
1.05
x
|
1.56
x
|
Nbr of stocks (in thousands)
|
15,233
|
15,319
|
15,359
|
15,423
|
15,344
|
15,325
|
Reference price
2 |
78.45
|
86.43
|
66.41
|
67.94
|
59.50
|
92.42
|
Announcement Date
|
2/20/19
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
978.7
|
996.4
|
977.9
|
1,011
|
1,074
|
1,135
|
EBITDA
1 |
101
|
94.59
|
88.96
|
58.86
|
57.76
|
93.26
|
EBIT
1 |
59.1
|
52.17
|
46.94
|
18.19
|
17.27
|
51.23
|
Operating Margin
|
6.04%
|
5.24%
|
4.8%
|
1.8%
|
1.61%
|
4.51%
|
Earnings before Tax (EBT)
1 |
74.88
|
88.02
|
52.42
|
150
|
27.23
|
88.74
|
Net income
1 |
58.96
|
68.21
|
41.87
|
138.6
|
22.44
|
66.8
|
Net margin
|
6.02%
|
6.85%
|
4.28%
|
13.71%
|
2.09%
|
5.88%
|
EPS
2 |
3.870
|
4.440
|
2.720
|
8.990
|
1.450
|
4.340
|
Free Cash Flow
1 |
43.1
|
51.17
|
151
|
-42.99
|
-44.49
|
57.9
|
FCF margin
|
4.4%
|
5.14%
|
15.44%
|
-4.25%
|
-4.14%
|
5.1%
|
FCF Conversion (EBITDA)
|
42.68%
|
54.1%
|
169.76%
|
-
|
-
|
62.08%
|
FCF Conversion (Net income)
|
73.1%
|
75.02%
|
360.67%
|
-
|
-
|
86.67%
|
Dividend per Share
2 |
1.980
|
2.060
|
2.080
|
2.110
|
2.260
|
2.340
|
Announcement Date
|
2/20/19
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
29.3
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
105
|
-
|
129
|
89.4
|
56.7
|
130
|
Leverage (Debt/EBITDA)
|
-
|
0.3092
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
43.1
|
51.2
|
151
|
-43
|
-44.5
|
57.9
|
ROE (net income / shareholders' equity)
|
8.16%
|
8.98%
|
5.32%
|
16.3%
|
2.24%
|
7.3%
|
ROA (Net income/ Total Assets)
|
3.39%
|
2.75%
|
2.22%
|
0.82%
|
0.81%
|
2.48%
|
Assets
1 |
1,738
|
2,476
|
1,890
|
16,858
|
2,785
|
2,698
|
Book Value Per Share
2 |
48.10
|
50.80
|
51.70
|
58.40
|
56.90
|
59.20
|
Cash Flow per Share
2 |
2.830
|
3.280
|
9.570
|
6.960
|
3.820
|
6.980
|
Capex
1 |
29.8
|
26.4
|
21.9
|
39.4
|
30.2
|
27.9
|
Capex / Sales
|
3.04%
|
2.65%
|
2.24%
|
3.9%
|
2.81%
|
2.46%
|
Announcement Date
|
2/20/19
|
2/21/20
|
2/19/21
|
2/18/22
|
2/17/23
|
2/16/24
|
|
1st Jan change
|
Capi.
|
---|
| +2.74% | 1.46B | | -17.59% | 2.39B | | +21.31% | 1.36B | | -24.59% | 1.43B | | +31.77% | 809M | | -10.00% | 435M | | +234.05% | 424M | | -4.39% | 341M | | +9.41% | 136M | | +46.75% | 95.92M |
Residential & Long-Term Care
|